NCT05899595

Brief Summary

Chronic fatigue (CF) is a pathological fatigue over at least 6 months, without improvement after rest or sleep. In primary care, it is the major complaint in 5 to 10% of the consultations. Physical activity is an efficient therapy to help reducing this fatigue in addition to the improvement of muscular and cardiorespiratory functions. However, it remains little exploited. Yet the studies focus mainly on precise chronic pathologies with general trainings, without considering the fatigue status and reveal a large heterogeneity. Personalizing the physical training appears to be the next step in order to improve chronic fatigue patients care. The objective of this study will be to investigate the relevance and the effects of a personalized physical training to reduce fatigue in chronic fatigue patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
18mo left

Started Sep 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Sep 2023Nov 2027

First Submitted

Initial submission to the registry

June 2, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 12, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

September 27, 2023

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 8, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 8, 2027

Last Updated

September 20, 2024

Status Verified

September 1, 2024

Enrollment Period

4.1 years

First QC Date

June 2, 2023

Last Update Submit

September 19, 2024

Conditions

Keywords

FatigueNeuromuscular functionPersonalized trainingPhysical capacityFatigue status

Outcome Measures

Primary Outcomes (1)

  • The primary outcome is the change in the FACIT-F score obtained before and after the exercise procedure.

    The FACIT-F (Functional Assessment of Chronic Illness Therapy) is a short questionnaire consisting of 13 questions which the patient answers on a scale of 0 to 4. The scores are simply added together, inverting the scale for negative sentences, to give a result out of 52 points. The lower the score, the greater the fatigue.

    Month 1, 4

Study Arms (2)

Personalized training group with the fatigue status (PERSO)

EXPERIMENTAL

The PERSO group will perform similar exercises as the RECO group but the training load will be adapted by changing the intensity (with the same volume as RECO) depending on the fatigue scores of the week. The aerobic fatigue score will set the load for the aerobic exercises and the muscle fatigue score for the resistance exercises.

Other: Exercise protocol

Traditional training group following the recommendations (RECO)

ACTIVE COMPARATOR

The RECO group will perform aerobic and resistance exercises to reach the recommendations for patients with chronic pathologies, with a moderate intensity and an increasing volume.

Other: Exercise protocol

Interventions

Patients will be randomly assigned to the PERSO or the RECO group. Each week, fatigue status of the patients will be assessed with four evaluations: * Subjective fatigue (Rate of Fatigue scale) * Heart rate variability with a holter ECG * Muscle pain with a visual analogue scale * Muscle fatigue with muscular electrical stimulations with the Myocene® The two first correspond to an aerobic fatigue score and the two latter to a muscle fatigue score. The RECO group will perform aerobic and resistance exercises to reach the recommendations for patients with chronic pathologies, with a moderate intensity and an increasing volume. The PERSO group will perform similar exercises as the RECO group but the training load will be adapted by changing the intensity (with the same volume as RECO) depending on the fatigue scores of the week. The aerobic fatigue score will set the load for the aerobic exercises and the muscle fatigue score for the resistance exercises.

Personalized training group with the fatigue status (PERSO)Traditional training group following the recommendations (RECO)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged ≥ 18
  • Men or women
  • FACIT-F score ≤ 34
  • Ability to walk during 10 minutes without stopping
  • Ability to receive the Myocene® stimulation protocol
  • Have given written consent
  • Members or beneficiaries of a social security program

You may not qualify if:

  • Contraindication to experimental procedures
  • Important health issues that would compromise the participant security during the study
  • Persistent atrial fibrillation or 2nd or 3rd degree atrioventricular block
  • Currently participating in an other interventional study or having so in the past thirty days
  • Patient is pregnant
  • Patient is unable to give an informed consent
  • Patient is deprived of liberty or under guardianship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier de Saint-Etienne

Saint-Etienne, 42055, France

RECRUITING

MeSH Terms

Conditions

Fatigue Syndrome, ChronicFatigue

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesEncephalomyelitisNeuroinflammatory DiseasesNervous System DiseasesNeuromuscular DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • David HUPIN, MD

    CHU SAINT-ETIENNE

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 2, 2023

First Posted

June 12, 2023

Study Start

September 27, 2023

Primary Completion (Estimated)

November 8, 2027

Study Completion (Estimated)

November 8, 2027

Last Updated

September 20, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations